【乳癌】乳癌篩檢「CLAIRITY BREAST」獲得FDA De Novo授權

 【乳癌】乳癌篩檢「CLAIRITY BREAST」獲得FDA De Novo授權

 文章出處  

Businesswire 

 

 原文標題  

ADDING MULTIMEDIA Clairity Becomes the First FDA-Authorized AI Platform for Breast Cancer Prediction – Historic Milestone for Women’s Health 

 

 Twitter  

https://x.com/aimedadviser/status/1932575552449490970 

 

 文章序號  

8239 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2025 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.